Literature DB >> 28352350

Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.

Lin Tang1, Shu-Juan Tong1, Zhen Zhan1, Qian Wang1, Yuan Tian2, Feng Chen2.   

Abstract

The present study aimed to analyze the expression and effects of NUAK2 in gastric cancer and adjacent normal gastric tissues. The protein expression levels of NUAK2 were detected by western blot analysis. The effects of NUAK2 expression on the proliferation of gastric cancer cells was detected using an MTT and BrdU incorporation assay. Furthermore, the effects of NUAK2 on proliferation and cancer stem cell markers, both protein and microRNA (miRNA), were investigated by western blot analysis and miRNA microarrays, respectively. The results demonstrated that NUAK2 was able to significantly promote the proliferation of SGC-7901 gastric cancer cells. In addition, NUAK2 overexpression decreased the percentage of cells in the G1 phase and increased the percentage of cells in the S phase. Western blot analysis and miRNA microarrays revealed that overexpression of NUAK2 resulted in increased expression levels of proliferation markers, including c-myc, proliferating cell nuclear antigen, cyclin-dependent kinase 2, miRNA 21, and gastric cancer stem cell markers, including aldehyde dehydrogenase 1, CD44 and CD133. In conclusion, NUAK2 expression differed between the tumor and normal gastric tissues. NUAK2 was able to promote the proliferation of gastric cancer cells and regulate their cell cycle. Proliferation and cancer stem cell markers were upregulated by NUAK2 expression. Therefore, the results from the present study suggest that NUAK2 may be a promising target for gastric cancer therapy in the future.

Entities:  

Keywords:  NUAK2; gastric cancer; microRNA; proliferation

Year:  2016        PMID: 28352350      PMCID: PMC5348656          DOI: 10.3892/etm.2016.3983

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  MicroRNA expression analysis using the Affymetrix Platform.

Authors:  Suzanne Dee; Robert C Getts
Journal:  Methods Mol Biol       Date:  2012

2.  MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer.

Authors:  F Chen; Y Tian; E-J Pang; Y Wang; L Li
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

3.  Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.

Authors:  Juntao Lang; Xiaoli Lan; Yu Liu; Xueyan Jin; Tao Wu; Xun Sun; Qiong Wen; Rui An
Journal:  Nucl Med Biol       Date:  2015-01-09       Impact factor: 2.408

4.  Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.

Authors:  Xing-Hua Liao; Da-Lin Lu; Nan Wang; Long-Yue Liu; Yue Wang; Yan-Qi Li; Ting-Bao Yan; Xue-Guang Sun; Peng Hu; Tong-Cun Zhang
Journal:  FEBS J       Date:  2014-01-02       Impact factor: 5.542

Review 5.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

6.  Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma.

Authors:  Po Zhao; Yazhuo Li; Yali Lu
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

7.  Identification of a novel substrate for TNFalpha-induced kinase NUAK2.

Authors:  Hiroyuki Yamamoto; Seiji Takashima; Yasunori Shintani; Satoru Yamazaki; Osamu Seguchi; Atsushi Nakano; Shuichiro Higo; Hisakazu Kato; Yulin Liao; Yoshihiro Asano; Tetsuo Minamino; Yasushi Matsumura; Hiroshi Takeda; Masafumi Kitakaze
Journal:  Biochem Biophys Res Commun       Date:  2007-11-20       Impact factor: 3.575

8.  Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.

Authors:  Caiping Gao; Zhiyu Zhang; Wenzhong Liu; Shudong Xiao; Weiqi Gu; Hong Lu
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

9.  miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Authors:  Shou-Mei Yang; Cheng Huang; Xiao-Feng Li; Ming-Zhe Yu; Yong He; Jun Li
Journal:  Toxicology       Date:  2013-03-04       Impact factor: 4.221

Review 10.  NUAK2: an emerging acral melanoma oncogene.

Authors:  Takeshi Namiki; Sergio G Coelho; Vincent J Hearing
Journal:  Oncotarget       Date:  2011-09
View more
  4 in total

1.  MiR-1179 represses cell proliferation, migration and invasion of hepatocellular carcinoma through suppression of NUAK2.

Authors:  Dejun Wang; Xue Song; Nan Zhang; Yesong Guo
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  NUAK2 silencing inhibits the proliferation, migration and epithelial‑to‑mesenchymal transition of cervical cancer cells via upregulating CYFIP2.

Authors:  Yuxia Li; Xiaohui Song; Liping Liu; Lei Yue
Journal:  Mol Med Rep       Date:  2021-09-24       Impact factor: 2.952

3.  NUAK2 is a critical YAP target in liver cancer.

Authors:  Wei-Chien Yuan; Brian Pepe-Mooney; Giorgio G Galli; Michael T Dill; Hai-Tsang Huang; Mingfeng Hao; Yumeng Wang; Han Liang; Raffaele A Calogero; Fernando D Camargo
Journal:  Nat Commun       Date:  2018-11-16       Impact factor: 14.919

4.  PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer.

Authors:  Suresh Kari; Vasyl V Vasko; Shivam Priya; Lawrence S Kirschner
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.